Initial cerebrospinal fluid-restricted oligoclonal bands associate with anti-N-methyl-D-aspartate receptor encephalitis severity: a pilot study
encephalitis · 2020
DOI: 10.47936/encephalitis.2020.00038 ↗Kurz gefasst
Fachartikel in der Zeitschrift encephalitis, 2020. Verfasst von Sang Bin Hong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Seoul National University Hospital, Seoul, Korea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Seoul National University Hospital, Seoul, Korea.
- Department of Neurosurgery, Center for Hospital Medicine, Seoul National University Hospital, Seoul, Korea.
- Rare Disease Center, Seoul National University Hospital, Seoul, Korea.
ORCID-Profile: Kon Chu
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
Zitieren
APA
Hong, S. B., Shin, Y. W., Moon, J., Lee, W. J., Chu, K., & Lee, S. K. (2020). Initial cerebrospinal fluid-restricted oligoclonal bands associate with anti-N-methyl-D-aspartate receptor encephalitis severity: a pilot study. encephalitis. https://doi.org/10.47936/encephalitis.2020.00038
Vancouver
Hong SB, Shin YW, Moon J, Lee WJ, Chu K, Lee SK. Initial cerebrospinal fluid-restricted oligoclonal bands associate with anti-N-methyl-D-aspartate receptor encephalitis severity: a pilot study. encephalitis. 2020. doi:10.47936/encephalitis.2020.00038
BibTeX
@article{Hong2020,
author = {Hong, Sang Bin and Shin, Yong-Won and Moon, Jangsup and Lee, Woo-Jin and Chu, Kon and Lee, Sang Kun},
title = {Initial cerebrospinal fluid-restricted oligoclonal bands associate with anti-N-methyl-D-aspartate receptor encephalitis severity: a pilot study},
journal = {encephalitis},
year = {2020},
doi = {10.47936/encephalitis.2020.00038}
}
EUVIMED